Washington University School of Medicine recently received a two-year grant of $360,000 from JDRF to fund research testing the efficacy of the Biosense handheld breath ketone monitor in persons with type 1 diabetes during care with insulin and with the addition of a sodium glucose transporter inhibitor drug. Biosense is a non-invasive option to capillary […]
On September 12, Alexis McKee, MD published an article on “EndocrineWeb,” titled “What Is the Peak Time for NPH Insulin?” “Insulin is a lifesaving hormone that is necessary for cells in your body to absorb sugar (glucose). Depending on the type of diabetes mellitus a person has, there can be a complete absence of insulin (type […]
On June 1, Janet B. McGill, MD, MA, FACP, Maamoun Salam, MD and colleagues has their work titled “Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use among Older Adults with Type 1 Diabetes,” published in “Diabetes Technology and Therapeutics.” In the study, they evaluate the Wireless Innovation for […]
On July 18, Kelley Williams, MD was selected to receive the “LeJIT” Teaching Award for her excellence during the 2022 Block 3 Medicine Clerkship from May through June. The award recognizes how Dr. Williams completed just-in-time (JIT) assessments and integrated them into her clinical and teaching workflows, providing meaningful and timely feedback to students. […]